News / Health

New Malaria Drug Shows Promise in Animal Tests

Art Chimes
U.S. researchers have developed a new fast-acting drug against malaria that appears to avoid the problem with current medicines, which often lose their effectiveness against increasingly drug-resistant strains of malaria parasites, called Plasmodium.
 
Scientists say the new malaria medicine may have a decisive edge against this persistent tropical-world killer.
 
Michael Riscoe of Oregon Health and Science University, in the U.S. Northwest, says the new drug, known as ELQ-300, targets the mitochondria -- energy-producing structures in the parasite’s cells -- and the DNA building blocks they produce.
 
A chemical model of ELQ-300. (Image courtesy of Michael Riscoe)A chemical model of ELQ-300. (Image courtesy of Michael Riscoe)
x
A chemical model of ELQ-300. (Image courtesy of Michael Riscoe)
A chemical model of ELQ-300. (Image courtesy of Michael Riscoe)
“So the Plasmodium mitochondrion serves as a factory to make these DNA building blocks, but this is completely blocked by ELQ-300," explains Riscoe. "Studies show that the drug acts very quickly to shut down this process. In fact, (in) only about 10 minutes.”
 
Perhaps the biggest obstacle in the fight against malaria, Riscoe adds, is the Plasmodium parasite’s ability to mutate and develop resistance to each new drug used against the disease. In tests using laboratory animals, he notes, the parasite did not develop resistant to ELQ-300.  “These findings suggest that if the drug is eventually developed for human use, then it could enjoy a long, useful clinical life before resistance emerges in the field.”  
 
That would be good news, because Riscoe says the new drug seems to be much more effective than current anti-malaria medicines.  “ELQ-300 is about 30 times more effective at curing malaria in mice as compared to atovaquone, a drug that’s in clinical use today.”
 
Riscoe and his colleagues cite other advantages to ELQ-300: it may be cheaper to make than existing drugs, and it may be effective at lower doses. They suggest it could be used in combination with another drug to cure malaria with just one dose of medicine. 
 
After successful tests on laboratory mice, ELQ-300 is heading for human trials, starting with tests for safety. 
 
Michael Riscoe was interviewed in a podcast by Science Translational Medicine, the journal which published his research.

You May Like

UN Watchdog Urges Israel to Probe Possible Gaza War Crimes

More than 2,100 Palestinians, most of them civilians, were killed in a 51-day war in Gaza, along with 67 Israeli soldiers and six civilians in Israel More

New Kenyan 'Thin SIMs' Poised to Transform African Mobile Money

Equity's new technology is approved in African nation for one-year trial, though industry leader Safaricom says thin SIMs could lead to data theft and fraud More

Solar's Future Looks Brighter

New technology and dropping prices are contributing to a surge in solar power More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Talks to Resume on Winter Gas for Ukrainei
X
Al Pessin
October 25, 2014 4:21 PM
Ukrainian and Russian officials will meet again next week in an effort to settle their dispute over natural gas supplies that threatens to leave Ukraine short of heating fuel for the coming winter. VOA’s Al Pessin reports from London the dispute is complex, and has both economic and geopolitical dimensions.
Video

Video Talks to Resume on Winter Gas for Ukraine

Ukrainian and Russian officials will meet again next week in an effort to settle their dispute over natural gas supplies that threatens to leave Ukraine short of heating fuel for the coming winter. VOA’s Al Pessin reports from London the dispute is complex, and has both economic and geopolitical dimensions.
Video

Video Smugglers Offer Cheap Passage From Turkey to Syria

Smugglers in Turkey offer a relatively cheap passage across the border into Syria. Ankara has stepped up efforts to stem the flow of foreign fighters who want to join Islamic State militants fighting for control of the Syrian border city of Kobani. But porous borders and border guards who can be bribed make illegal border crossings quite easy. Zlatica Hoke has more.
Video

Video China Political Meeting Seeks to Improve Rule of Law

China’s communist leaders will host a top level political meeting this week, called the Fourth Plenum, and for the first time in the party’s history, rule of law will be a key item on the agenda. Analysts and Chinese media reports say the meetings could see the approval of long-awaited measures aimed at giving courts more independence and include steps to enhance an already aggressive and high-reaching anti-corruption drive. VOA’s Bill Ide has more from Beijing.
Video

Video After Decades of Pressure, Luxembourg Drops Bank Secrecy Rules

European Union finance ministers have reached a breakthrough agreement that will make it more difficult for tax cheats to hide their money. The new legislation, which had been blocked for years by countries with a reputation as tax havens, was approved last week after Luxembourg and Austria agreed to lift their vetoes. But as Mil Arcega reports, it doesn’t mean tax cheats have run out of places to keep their money hidden.
Video

Video Kobani Refugees Welcome, Turkey Criticizes, US Airdrop

Residents of Kobani in northern Syria have welcomed the airdrop of weapons, ammunition and medicine to Kurdish militia who are resisting the seizure of their city by Islamic State militants. The Turkish government, however, has criticized the operation. VOA’s Scott Bobb reports from southeastern Turkey, across the border from Kobani.
Video

Video US ‘Death Cafes’ Put Focus on the Finale

In contemporary America, death usually is a topic to be avoided. But the growing “death café” movement encourages people to discuss their fears and desires about their final moments. VOA’s Jerome Socolovsky reports.
Video

Video Ebola Orphanage Opens in Sierra Leone

Sierra Leone's first Ebola orphanage has opened in the Kailahun district. Hundreds of children orphaned since the beginning of the Ebola outbreak face stigma and rejection with nobody to care for them. Adam Bailes reports for VOA about a new interim care center that's aimed at helping the growing number of children affected by Ebola.

All About America

AppleAndroid